(A–B) Bid-deficient hepatocytes were infected with adenoviral GFP, GFP-Bid and ER-targeted GFP-Bid-b5 for 24 hours. Immunoblot assay was conducted with an anti-GFP and an anti-Bid antibody (A). Fluorescence microscopic examination demonstrated the cellular localization of these constructs (B). Note the ER location pattern of GFP-Bid-b5 in the enlarged panel. Scale bar: 10 µm. (C–D) Bid-deficient hepatocytes were infected with adenoviral GFP, GFP-Bid and GFP-Bid-b5 as indicated for overnight in serum-free medium. Cells were then cultured in medium containing 10% serum for the indicated time with BrdU included in the last 24 hours. The percentages of nuclei with BrdU incorporation in GFP, GFP-Bid or GFP-Bid-b5-positive hepatocytes were determined (C). Data (mean± SD) represented at least three independent experiments. p<0.01 (GFP-Bid-b5 vs GFP and vs GFP-Bid, 24 hr); p<0.05 (GFP-Bid vs GFP, 48 hr); p<0.01 (GFP vs GFP-Bid and vs GFP-Bid b5, 72 hr). Lysates were collected and immunoblot assay was conducted with indicated antibodies (D). (E). Subcellular fractions from wild type livers were subjected to immunoblot assay with the indicated antibodies. 14-3-3ε, VDAC and calnexin were used as controls for the cytosol (S10, S100), mitochondrial (P10) and ER (P100) fractions, respectively. Asterisks indicate non-specific bands. (F). The ER-enriched P100 fraction obtained from wild type mouse livers was either untreated (control, lane 1) or treated with 0.1M Na2CO3 (pH 11.5) on ice for 30 min, following by centrifugation (100,000 × g) for 30 min. Both the pellet (membrane fraction, lane 2) and the supernatant (lane 3) of alkali-treated sample were recovered for immunoblot assay. (G). Wild type (WT) hepatocytes were cultured in medium with 10% serum for 24 hours and then harvested. Subcellular fractions of S100 and P100 (Lane 1–2) were analyzed by immunoblot. The total lysate of bid−/− MEF (Lane 3) was used as a control for Bid signal.